NCCN 2023 Annual Conference
Advertisement
The approved dosing schedule for venetoclax is time-limited, but how many patients follow the schedule?
Though rare, CLL and CML sometimes occur sequentially or concurrently. But what is the mechanism behind the relationship?
In a currently enrolling trial, patients with CLL and NMSC will receive experimental treatment with nicotinamide.
Deborah Stephens, DO, presented the recommendations and algorithms for first-, second-, and third-line CLL/SLL therapy.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.